ScholarIQanswers from OpenAlex

Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon <i>epidermal growth factor receptor</i> mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor?

PaperCitations, authors & open-access status

Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon <i>epidermal growth factor receptor</i> mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor? is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon <i>epidermal growth factor receptor</i> mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor? have?

ScholarIQcitation count

Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon <i>epidermal growth factor receptor</i> mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor? has 89 citations in the OpenAlex counts ScholarIQ stores.

When was Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon <i>epidermal growth factor receptor</i> mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor? published?

ScholarIQyear

Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon <i>epidermal growth factor receptor</i> mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor? has 2016 year in the ScholarIQ index.

What is the open-access status of Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon <i>epidermal growth factor receptor</i> mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor??

ScholarIQoa status

Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon <i>epidermal growth factor receptor</i> mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor? has gold oa status in the ScholarIQ index.

What is the DOI of Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon <i>epidermal growth factor receptor</i> mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor??

ScholarIQdoi

The DOI for Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon <i>epidermal growth factor receptor</i> mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor? is on the source record.

What is the PMID of Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon <i>epidermal growth factor receptor</i> mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor??

ScholarIQpmid

The PMID for Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon <i>epidermal growth factor receptor</i> mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor? is on the source record.

What is the OpenAlex record for Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon <i>epidermal growth factor receptor</i> mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor??

ScholarIQopenalex

The OpenAlex for Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon <i>epidermal growth factor receptor</i> mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor? is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial